Reported 2 months ago
Demecan Group, a prominent cannabis producer in Germany, has secured additional funding which brings its valuation close to 100 million euros. This funding round, predominantly led by U.S.-based Trog Hawley Capital, marks a significant step for overseas investment in Germany's medical cannabis sector. The company aims to utilize the funds to enhance its online selling platform and continue expanding in Europe's largest medical cannabis market.
Source: YAHOO